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Abstract 
Purpose: The Smart Heart Self-Care First Pilot Program (SHSCF) offers a transitional care 
intervention focusing on the self-care of hospitalized heart failure patients who are discharged 
home. It utilizes assessment, communication and education components to encourage behavior 
modification (improved self-care) through telehealth methodology. 
 
Background and Significance: Heart failure related admissions, as a primary or secondary 
diagnosis, are among the leading causes of hospitalizations in the United States (Emory 
Healthcare, 2016). Surprisingly, of those patients discharged with a primary diagnosis of heart 
failure, 20% are readmitted to the hospital within thirty days (Feltner et. al, 2014). Heart failure 
related re-hospitalizations highlight a growing need for transitional care from the inpatient 
setting to the home. Thus, heart failure self-management programs focusing on self-care skills 
and education are becoming increasingly popular among institutions (Baker et al., 2011).  
 
Procedures: Twenty participants were enrolled into this randomized controlled trial. Twelve 
patients received the usual or standard of care based on Heart Failure Core Measures and the 
other 8 participants received the text messaging intervention. Assessment of self-care, depression 
symptoms and anxiety symptoms was obtained at baseline and at the 30-day follow-up time 
frame. For those patients in the intervention group, the delivery of text messages was daily for 
thirty days after discharge. Additional outcomes evaluated post intervention included hospital 
readmissions and quality of life. 
Results: The sample was primarily male (70%), Caucasian (85%), urban (60%), mostly middle 
aged (mean age= 49.1, SD= 14.9) and not currently married (60%). On average, participants had 
mild depression and anxiety symptoms (mean PHQ-9=7.2, SD=5.1; mean GAD-7=5.3, SD=5.6) 
of which 25% of the intervention and 33.3% of the control group had moderate to severe 
depression symptom scores. There were no significant differences in self-care, depression 
symptoms, or anxiety symptoms between the control and intervention groups pre and post 
intervention. There was a readmission rate of 25% in both the intervention and control groups. 
Implications for Nursing Practice: Self-management programs offer hope to providers and 
patients as they transition from an acute care facility to home.  Specifically, telehealth methods 
show promise in increasing provider and patient communication as well as access to specialty 
care. This program highlights how the routine screening for depression and anxiety symptoms in 
addition to education could be beneficial in the HF population, encompassing a holistic approach 
to care through the evaluation of emotional and not just physical health. 
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The Smart Heart Self-Care First Pilot Program 
Patient engagement can be influenced by a patient’s confidence, motivation, and 
determination to be active in their care (James, 2013). Patient activation as referred to by James 
(2013), explains that those patients who are willing to develop the skills needed to care for 
themselves as well as modify their behavior may have better outcomes compared to those 
patients who lack activation. In the context of heart failure (HF), patient engagement is essential 
to the prevention of hospitalization, early mortality, and advancing disease.  The physical 
symptoms experienced by patients with HF may contribute to psychological well-being, 
indicating an overlap between emotional and physical health.  This overlap may account for the 
ability to care for oneself, called self-care, and may help to predict those patients at greater risk 
for poor clinical and psychological outcomes.  The Smart Heart Self-Care First (SHSCF) Pilot 
Program was designed with this concept in mind. The planning, implementation, and evaluation 
process of this pilot study will be outlined. 
Background & Significance 
Approximately 5.8 million people in the United States have heart failure (HF), an 
estimate projected to increase by 3 million by the year 2030 (Feltner et. al, 2014).  Within this 
population, approximately 50% of people will die within 5 years of being diagnosed, 
contributing to an alarming mortality rate (Centers for Disease Control and Prevention, 2016).  In 
2011, 58,309 deaths were attributed to HF, accounting for 1 in 9 causes of death in the United 
States, signifying the value of research on interventions to improve HF outcomes (CDC, 2016). 
In addition to escalating mortality rates, an annual cost of $30.7 billion related to HF in 
lost productivity, health care services, and medications plagues the United States (CDC, 2016).   
Approximately 11 million provider visits each year are attributed to HF and it is the leading 
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diagnosis in 875,000 hospitalizations in patients greater than 65 years of age (Emory Healthcare, 
2016).  HF-related admissions, as a primary or secondary diagnosis, are among the leading cause 
of hospitalizations in the United States which is approximately 20% (Emory Healthcare, 2016).  
Surprisingly, of those patients discharged with a primary diagnosis of HF, 20% are readmitted to 
the hospital within thirty days (Feltner et al, 2014).  A reduction or absence of reimbursement for 
care as an implication of the Affordable Care Act has gained the attention of institutions 
nationwide to address this problem of HF-related 30 day re-admissions (Feltner et al, 2014).  
There are several factors that affect HF outcomes, especially psychological co-
morbidities.  Mood disorders, such as anxiety and depression, are psychological conditions that 
may impair physical and emotional functional status.  It has been suggested that depression 
specifically, may result in poorer HF outcomes such as increased mortality, more frequent 
hospitalizations, and decreased functional status (Polikandrioti et al., 2015).  According to 
Polikandrioti et al. (2015), the failure to recognize symptoms of depression and anxiety may 
account for the alarmingly high mortality rate the HF population still faces.  It has been 
suggested that these symptoms are frequently missed by healthcare providers and not adequately 
treated which could have major implications on adherence to treatment regimens (Polikandrioti 
et al., 2015).  Therefore, the recommendation set forth by the American Heart Association 
(AHA) in 2009 to routinely screen for depression in patients with HF is likely to capture those 
patients at risk for poor self-care and intervene early.  
This highlights a growing need for transitional care from the inpatient setting to the home 
within each community.  Disease management programs focusing on self-care interventions and 
education are becoming increasingly popular among institutions (Baker et al., 2011).  Self-care 
can be defined as those behaviors incorporated into a person’s daily routine that optimize HF 
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therapies including daily weights, salt restriction, daily exercise, medication adherence, smoking 
cessation, and maintaining a well-balanced diet (Lee et al., 2015).  Providers expect that 
assessment and targeted multifaceted interventions promoting HF self-care will improve self-
care behaviors, decrease HF specific readmissions to the hospital, improve patient outcomes and 
disease management, improve quality of life, and reduce annual costs. 
Biopsychosocial Holistic Model of Cardiovascular Health 
            In the biopsychosocial holistic model, the biological, psychological, and social realms of 
health interact with one another (Thomas et al., 2008).  An imbalance or disruption of any of the 
domains can lead to increased disease severity (of any kind) and acute decline (Lloyd-Jones et 
al., 2010; Thomas et al., 2008).  This model can be applied to any chronic disease process but is 
especially useful in explaining why patients with HF may need psychological intervention and 
social support in addition to medical management to slow the progression of HF. 
Specifically, depression and anxiety, psychological realms of health, interact with 
biological processes in HF by decreasing neuro-hormonal regulation (Holsboer & Ising, 2008; 
Cameron, Abelson, & Young, 2004), disruption of the autonomic nervous system (Licht, de 
Geus, Zitman et al., 2008; Licht, de Geus, van Dyck et al., 2009), and promotion of 
inflammatory pathways through cytokine and platelet activation (Morel-Kopp et al., 2009; Leo et 
al., 2006; Zafar et al., 2010). Depression and anxiety share similar pathophysiological pathways 
with HF, suggesting that their co-morbidities may have an amplified detrimental effect on HF. 
Objectives 
The Smart Heart Self-Care First Program (SHSCF) offers a transitional care intervention 
focusing on the self-care of hospitalized HF patients who are discharged home.  It utilizes 
assessment, communication, and education components as its foundation to encourage an 
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overarching goal of behavior modification (improved self-care).  The goal of this program is to 
facilitate improved self-care through telehealth interventions, provide increased communication 
with patients after discharge and throughout the transitional period.  The purpose of the 
evaluation project is to assess the implementation of the telehealth intervention and make 
changes so that the objectives of the intervention can be met. The specific aims of this program 
are:  
 Assess HF self-care for each participant utilizing the Self-Care Heart Failure Index Tool 
(SCHFI).  
 Reinforce HF self-care education after discharge through telehealth interventions (daily 
text messaging) 
 Improve and increase communication with HF patients after discharge through telehealth 
interventions.  
 Improve HF self-care scores after the intervention.  
 Prevent readmission to the hospital within 30 days of discharge.  
Study Design 
This study was based on a randomized control trial of 20 participants from a cohort of 
hospitalized HF patients at the University of Kentucky (UK) Chandler Medical Center.  
Participants were selected for randomization based on a pre-determined ordering (See Table 1).  
Although the initial target was 30 participants, due to time-constraints, only 20 were recruited.   
The control group for this study (Group 1) received usual care and were administered 
SCHFI at discharge and then again thirty days after discharge. The usual care was derived from 
HF Core Measures Education Packet which includes assistance from a discharge planner for the 
coordination of home health services, ensuring access to medications, establishing a follow-up 
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appointment within one to two weeks of discharge, and HF education based on Core Measures 
provided by the staff nurse.  
The intervention group (Group 2) were also given the HF Core Measure Education 
packet and administered the SCHFI prior to discharge and at 30 days after the telehealth 
intervention.  In addition to the HF Core Measure Education, HF self-care text messages were 
sent from a website in which a patient phone number can be added as the only identifying 
information.  This concept of using a website for text delivery has been used before in a study 
evaluating self-care in the African American HF population (Nundy et al., 2013).  From the 
website, each participant received pre-programmed text messages at the same time of day each 
day for 30 days (See Appendix J for the list of automated pre-programmed text messages on HF 
self-care along with the patient and message list).  For each participant (identified as a 4-digit ID 
code), the time that the message was delivered (and that it was delivered successfully) was 
logged to ensure the proper dose of the intervention was delivered.  The website kept a log of 
how many participants were “active” at any given time which means that the participant was 
currently getting the text messages and how many messages had been received/sent.  It also 
showed which participants had received all the scheduled text messages; these participants were 
designated as “finished” vs. patients who were still receiving the intervention who were 
designated as “active.”  
A 30-day trial was performed to verify that the website worked consistently, ensuring the 
delivery of each text message in the correct sequence by the principal investigator.  When a 
patient was enrolled, they were sent a “test message” to ensure that the text messaging system 
was working appropriately as well as to confirm the number from which the messages were 
delivered.  This was not achievable in some scenarios if the patient’s cell phone was not charged 
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(on) or if the patient did not have their phone in the hospital because it was shared with a 
significant other.  For those participants, the number used by Twilio was written down and given 
to the participant to verify once they got home that they had received the test message.  Test 
messages were entered and verified on the website (See Figure 1).  Random letters were used for 
the name and no start date was entered to send the phone number verification test message.  
When the test message was ready to be sent the “send a test msg” turned from yellow to green.  
A check mark would appear next to that box to confirm delivery once the message was sent. 
Outcome Measures  
The primary outcomes of this study are changes in self-care score, and anxiety and 
depression symptom scales.  Long term outcomes of the study include quality of life (measured 
after the study in both control and intervention group; post -test only design), depressive 
symptoms, and anxious symptoms 1 month after the intervention as well as 30 day readmissions 
(see Table 2).  
Self-Care  
Self-care was measured by the SCHFI, which has been studied extensively for its validity 
and reliability.  SCHFI evaluates self-care maintenance, self-care management, and self-care 
confidence levels.  It also has 6 aspects of validity compared to the European Heart Failure Self-
Care Behavioral Scale 9 (EHFScBS-9) which has 5 aspects.  SCHFI shows changes in self-care 
over time more than the EHFScBS-9 (Cameron, Worrall-Carter, Driscoll, & Stewart, 2009; 
Jaarsma et. al., 2013; Lee et. al., 2013; Riegel & Dickson, 2008).  For this reason, SCHFI was 
chosen as the tool of choice to determine if the telehealth intervention in this study affected self-
care pre and post intervention.  Another reason why SCHFI was elected as the tool to determine 
self-care for this study was because it identifies the two symptoms (trouble breathing and ankle 
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swelling) most prevalent in patients with a heart failure exacerbation.   
Depression Symptoms  
Depressive symptoms were assessed with the Personal Health Questionnaire (PHQ-9; 
see Appendix C).  The PHQ-9 demonstrates evidence of reliability and validity in various other 
populations of hospitalized patients and in the outpatient setting (Hammash, Hall, Lennie, Heo, 
Chung, Suk Lee, & Moser, 2013).  The PHQ-9 has not been validated in heart failure patients 
but was chosen for its briefness and usability in assessing depressive symptoms compared to the 
Beck Depression Inventory II (BDI-II) that is much longer and requires more time to complete.  
Recently, in a study comparing the depressive symptoms of patients using the PHQ-9 and the 
Beck Depression Inventory showed that the PHQ-9 was a valid measure of depressive 
symptomology in HF patients (Hammash et al., 2013). This has important implications if the 
results are minimally clinically significant because the assessment of depressive symptoms 
should be assessed readily and promptly prior to discharge in an acute care setting.   
Anxiety Symptoms  
Anxiety symptoms were assessed using the Generalized Anxiety Disorder-7 Scale 
(GAD-7; see Appendix D).  Although the measurement of anxiety in heart failure patients has 
not yet been standardized, the GAD-7 was chosen for its ability to assess anxiety severity in the 
last two weeks (Kroenke, Spitzer, Williams, & Lowe, 2010).  The GAD-7 has correlation with 
other well established scales in heart failure patients such as the Beck Depression Inventory 
anxiety subscale (r=0.72) and demonstrates validity and internal consistency among primary 
care patients (Kroenke et al., 2010).   
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Quality of Life  
Quality of life was assessed with the Minnesota Living with Heart Failure Questionnaire-
21 (MLWHFQ-21; see Appendix E).  It measures physical (8 questions) and emotional (5 
questions) quality of life with a total of 21 items.  The scale is scored from 0-105 with 0 
indicating the best quality of life and increasing scores indicate poorer quality of life (Garin, et 
al., 2014).  The MLWHFQ-21, which has been extensively tested for reliability and validity, has 
also been used in 21 different countries, confirming it is the most widely used tool for health-
related quality of life (Garin et al., 2014).    
Readmission Rates  
Readmission rates within 30 days of discharge to an inpatient facility was examined as 
the proportion of participants within the intervention and control group that were readmitted 
within the 30-day intervention time-point.   The electronic medical record was used to retrieve 
this information as well as calling each participant to verify if they have been readmitted to the 
hospital.  For participants of the study who are admitted at other hospitals, this information will 
be retrieved by phone call.   
Study Population 
The University of Kentucky (UK) has an adequate amount of heart failure patients to 
include approximately 20 total patients (8 in the intervention group and 12 in the control group) 
over the course of 2 months into the pilot program.  Data collected by the UK finance 
department including UK Healthcare HF Inpatient Demographics (A. Carr, personal 
communication, August 3, 2015) was used to determine the sample for this intervention which 
was initially projected to be 50.  The sample mostly comprised patients from the Fayette, 
Madison, Clark, Jessamine, Laurel, Franklin, and Scott Counties in Kentucky.  The HF 
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population at UK has increased exponentially in recent years, serving approximately 3,449 
inpatient visits in 2014 compared to 4,005 patients just from January until June of 2015.  The 
major payer sources identified for the HF population served include 64% Medicare, 20.9% 
Medicaid, 10.1% Managed Care, and 5% self-pay or governmental insurance from January to 
June of 2015 (Table 3).  
Data collected as of August 2015, showed that the majority of inpatient discharges occur 
in patients older than 45 years (Table 4).  There are approximately 50-60 discharges each month 
with a primary diagnosis of HF, a number that reflects increasing admissions over the last few 
years and an adequate population to sample from for this pilot study (A. Carr, personal 
communication, August 3, 2015).  The demographic composition of the intervention group 
compared to the control group was assessed for significant differences to account for differences 
in outcomes.  
Inclusion Criteria 
 Patients eligible for participation include a primary HF diagnosis, ability to speak 
English, may have a LVAD, have a wireless telephone capable of receiving text messaging for 
30 days (adequate amount of data messaging or unlimited messaging on wireless plan), >18 
years of ages, and the ability to be discharged home.  Participants eligible for inclusion must be 
able to receive text messaging (one message received daily for 30 days) by allotting > 0.5 GB 
mobile data messaging through a wireless carrier of their choice.  
Exclusion Criteria 
 There was no exclusion based on sex/gender or racial/ethnic groups.  Exclusion criteria 
that must be met included those participants who were unable to read and did not speak English.  
Also, those who were pregnant were excluded from the study.  
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Methods 
Recruitment  
Recruitment of subjects occurred through HF providers at the University of Kentucky 
including an Inpatient Acute Care Nurse Practitioner and Patient Care Facilitator who organized 
the needs of patients with HF who could be discharged from the hospital.  Identification of 
patients who met the inclusion criteria was evaluated by these two members of the study team.  
They gave each eligible patient a flyer about the Smart Heart Self Care First Pilot Study 
(Appendix H).  If the patient was interested in participating and would like more information, 
study personnel communicated this interest with the PI to enroll the patient in the study.   
Informed Consent  
The PI was responsible for obtaining informed consent.  Occasionally, there was a brief 
waiting period between determination of eligibility to participate in the study (by study 
personnel) and obtaining informed consent.  This is because eligible participants were given a 
flyer by study personnel for them to decide if they were interested in participating in the study.  
Also, some patients were supposed to be discharged on a certain day but had complications that 
prolonged their hospital stay.  Some patients were enrolled a few days prior to discharge 
compared to other subjects who were enrolled on the day of their discharge home.  The consent 
process to participate in the SHSCF pilot study took approximately fifteen to thirty minutes on 
average.  After consent was obtained, the PI gave a copy of the consent form with highlighted 
contact information to each participant.  
The informed consent process also required explanation of the incentive to participate 
provided by the Health Education Library.  This incentive included a daily weight calendar to 
track weight and HF symptoms, a pill calendar organizer (with morning, lunch, evening, and 
bedtime time frames), as well as the HF Core Measure Education packet for each participant. 
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Data Collection Prior to Discharge  
Each participant received the standard of care for HF patients at discharge.  This includes 
the option to obtain medications from the Chandler Retail Pharmacy prior to discharge as well as 
HF education labeled as “Heart Failure Core Measures Education” under the Krames education 
tab on the electronic medical record in Sunrise Clinical Manager.  
After informed consent was obtained, the client was given a paper copy of a survey that 
evaluated comfort and use of text messaging from a mobile phone (See Appendix B).  This 
survey was developed by modifying and incorporating questions from a study by Nundy et al. 
(2013) to determine if the participant had a smart phone, the average use of a cell phone 
(frequency), if the participant had an unlimited texting plan, had used text messaging in the past, 
and the number of texts received per day. 
Next, a paper copy of the 1) PHQ-9 (Appendix C) 2) GAD-7 Scale (Appendix D) and 3) 
The Self-Care of Heart Failure Index tool (Appendix A) were given to the patient to fill out.  
Demographic information was obtained from the client’s electronic medical record as well as 
from a brief survey from the client with Appendix I (Demographic Information Form).  For 
patients who did not have their glasses or had trouble writing, these tools were read aloud by the 
PI. 
 To ensure safety, if a participant scored ≥ 10 on the PHQ-9 or GAD-7, their provider 
was notified.  A depression and anxiety symptom screening protocol (See Appendix G) was 
implemented to ensure follow-up of symptoms.  This study resulted in one participant requiring 
psychiatric consultation due to thoughts of self-harm or harm to others.  This delayed the 
participant’s discharge for up to 24 hours but they were not considered a harm to themselves and 
were sent home the next day.  
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Procedures for the Intervention Group  
On the day of discharge, study personnel confirmed the participant’s discharge from the 
hospital to home.  Their “final discharge summary” was evaluated for discharge medications. 
The next day, the client would receive a message welcoming them to the SHSCF pilot program 
at 9:15 am.  Then the client received one message every day for the next 30 days at the same 
time, 9:15 am each morning (See Appendix J). These texts included self-care information from 
HF patient teaching guide developed by the Robert Wood Johnson Foundation in 2011 that is a 
part of a national program called Expecting Success: Excellence in Cardiac Care (Bornstein et 
al., 2011). 
Data Collection Post Intervention  
On the 30th day after discharge, each participant in both the control and intervention 
groups received a telephone call to re-deliver the tools over the phone that were given prior to 
discharge 1) PHQ-9 (Appendix C) 2) GAD-7 Symptom Scale (Appendix D) and 3) SCHFI 
(Appendix A).  Also, the MLWHFQ-21 (Appendix E) was administered at this point in time.  
This took approximately twelve minutes to one hour to collect the post intervention data.  
Several of the participants were not easily reachable and required multiple voicemails left by the 
PI to enhance communication.  During the telephone interview, the PI confirmed any 
readmissions the client had during the 30 days immediately following discharge in addition to 
review of the electronic medical record.  This was performed to capture any readmissions to an 
inpatient facility for HF outside of UK.  Participants were then mailed a brief satisfaction survey 
(See Appendix F) to thank them for participation and gather feedback on the pilot study.  An 
envelope with return postage was included with this satisfaction survey.  
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Data Analysis  
Descriptive analysis included means with standard deviations for continuous variables 
and frequencies with percentages for categorical and ordered categorical variables.  Specifically, 
daily text messages received and discharge medications prescribed were described using 
frequencies and percentages.  Differences in baseline demographic and study variables between 
the intervention and control groups were examined using Fischer’s exact test for categorical data 
and independent sample t-tests (with Levene’s test for equality of variances) for continuous 
variables.  Changes in SCHFI, PHQ-9, GAD-7 scores were examined using paired sample t-tests. 
In addition, differences between the control and intervention groups in the MLWHFQ-21 scores 
were examined using independent sample t-tests at post intervention.  Finally, differences in the 
number of 30 day readmissions between the intervention and the control group was examined 
using chi-square analysis.  All data was analyzed using SPSS 22 and an alpha level of 0.05 was 
set for statistical significance in all analyses. 
Results 
Sample Characteristics  
The sample was primarily male (70%), Caucasian (85%), urban (60%), mostly middle 
aged (mean age= 49.1, SD= 14.9) and not married (60%).  On average, participants had a high 
school education or above (85%) and had a majority household income of <$20,000 (70%).  The 
majority of the sample was obese (mean body mass index=34.6, SD=11.9), had a New York 
Heart Association (NYHA) class greater than II (65%), and had a low left ventricular ejection 
fraction (LVEF) percentage (mean LVEF= 26.3%, SD=13.3).  Thirty-percent of the sample had a 
left ventricular assist device (LVAD) and the majority (85%) had a non-preserved LVEF.  
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On average, participants had mild depression and anxiety symptoms (mean PHQ-9=7.2, 
SD=5.1; mean GAD-7=5.3, SD=5.6) of which 25% of the intervention and 33.3% of the control 
group had moderate to severe depression symptom scores; and 0% of the intervention and 25% 
of the control group had moderate to severe anxiety symptom scores.  The sample had a mean 
HF self-care score of 61.5 (SD=11.9).  
There were also significant differences between the intervention and control groups in 
educational level and NYHA class.  At baseline, as compared to those in the control group, 
individuals in the intervention group were more likely to have a high school or greater education 
(100% vs. 75%, p=.02) and less severe NYHA class I or II (37.5% vs. 83.4%, p=.04). See Table 
5 for details. 
Data collected from the text messaging comfort survey (Appendix B) indicated that all 
participates owned a smart phone, could receive text messages, and had an adequate data plan 
that allowed them to receive the 30 texts if they were in the intervention group.  All subjects 
know how to open and view a text message and most carried their phone frequently.  The 
average daily use of text messaging is described in Figure 2.  There was no significant difference 
between the control and intervention groups in texts received per day and how often the 
participant carried their phone with them. 
 Medications prescribed at discharge to over 75% of participants in the intervention and 
control groups included beta blockers, diuretics, and anticoagulants (See Figure 3).  There were 
no differences between the control and intervention group in the medications prescribed at 
discharge.  Recommendations by the Joint Commission include the prescription of a beta blocker 
and angiotensin converting enzyme (ACE) inhibitor, or angiotensin receptor blocker (ARB) if 
unable to take an ACE inhibitor, to reduce mortality and improve survival if the left ventricular 
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ejection fraction is < 40% at discharge (Gardetto & Carroll, 2007).  The prescribing rate was 
>75% at discharge for both intervention and control groups for a beta blocker in comparison to 
ACE inhibitors or ARBs which was prescribed at a rate of less than 35%. 
Changes in self-care, depression symptoms, and anxiety symptoms 
 There were non-significant changes in self-care scores, depression symptom scores, and 
anxiety symptom scores from pre to post intervention (see Table 6).  In the total sample, self-care 
scores increased from an average of 61.1 [SD=11.2] pre-intervention to 65.2 [SD=9.2] at post 
intervention; albeit, these increases were non-significant [t= 1.4 (df=17), p= .19).  In the 
stratified analysis, similar non-significant increases were observed with the intervention group 
[Mean=65.7, SD= 11.7 to Mean= 67.6, SD=9.6] and the control group [Mean=58.2, SD= 10.3 to 
Mean= 63.6, SD=9.0] (see Figure 4). 
In the total sample, depression symptom scores decreased from an average of 6.9 
[SD=5.2] pre-intervention to 6.7 [SD=5.5] at post intervention; but, these decreases were non-
significant [t= - 0.2 (df=17), p= .86).  In the stratified analysis, similar non-significant decreases 
were observed with the intervention group [Mean=6.9, SD= 4.1 to Mean= 5.6, SD=2.6] 
compared to the control group which showed an increase in PHQ-9 scores [Mean=7.0, SD= 6.0 
to Mean= 7.4, SD=6.8] (see Figure 5). 
In the total sample, anxiety symptom scores increased from an average of 5.0 [SD=5.7] 
pre-intervention to 6.4 [SD=5.9] at post intervention; albeit, these increases were non-significant 
[t= 1.6 (df=17), p= .14).  In the stratified analysis, similar non-significant increases were 
observed with the intervention group [Mean=2.4, SD= 3.1 to Mean= 4.0, SD=3.4] and the 
control group [Mean=6.6, SD= 6.5 to Mean= 7.9, SD=6.8] (see Figure 6). 
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Differences in Quality of Life 
 There were non-significant differences in MLWHFQ-21 scores between the intervention 
and control groups.  After 30 days, the intervention group had lower sores in the MLWHFQ-21 
as compared to the control group [Mean=47.7 (SD=10.6) vs. Mean= 55.4 (SD=9.9), p= .62] (see 
Figure 7).  
Readmissions 
At 30-day follow-up, a total of 5 (20%; intervention group =2 vs. control group=3) 
participants had been readmitted to the hospital.  There were no significant differences in 30 day 
readmissions between the intervention and the control group (25% vs. 25%).  
Discussion of Findings 
Summary 
This pilot study is one of few studies to deliver a daily text-messaging intervention to HF 
patients to improve self-care and prevent readmissions.  The use of telehealth technology proves 
to be a clinically relevant answer to a multifaceted approach to transitional care of patients from 
the hospital to home in patients with HF.  Although there were no statistically significant 
changes or differences between the intervention and control group in all outcomes measures 
(self-care, depression symptoms, anxiety symptoms, hospital readmissions, and quality of life), 
they may have important implications for future research and nursing practice.  This pilot study 
indicates that telehealth interventions such as daily text message reminders about self-care may 
be labeled as a HF management program that promote HF education with a goal of improved 
patient outcomes (Smeulders, van Haastregt, van Hoef, van Eijk, & Kempen, 2006). 
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Depression and anxiety symptom prevalence 
 Previous researchers have noted approximately one fifth to one third of patients with HF 
were found to have co-morbid depression or clinical symptoms of depression in addition to 
patients with anxiety levels above those of the average healthy adult (Heo & Moser et al., 2007; 
Dekker et al., 2014; Goodman et al., 2013; Volz et al., 2011; Suzuki et al.,2014; Damen, Pelle, 
Szabo, & Pederson, 2011; Alhurani et al., 2014; Shen et al., 2011; Staniute et al., 2015; Chung et 
al., 2009).  These findings are comparable to this SHSCF pilot study because there was 25% and 
33.3% incidence of moderate to severe depression symptoms in the intervention and control 
groups respectively.  Although this pilot study did not have similar results for anxiety symptoms 
in the intervention group, the control group had a 25% incidence of moderate to severe anxiety 
symptoms; this is comparable to the research previously mentioned.  Interestingly, in one study, 
HF patients with depression or depressive symptoms were more likely to experience anxiety 
symptoms than patients without depressive symptoms (Dekker et al., 2014).  It is possible that 
with a larger sample, the proportion of participants who score moderate to severe on anxiety 
symptoms would increase and be comparable to other studies.   
 Furthermore, it is important to note the response of the providers who cared for the 
participants who scored moderate to severe in either depression or anxiety symptoms.  Some of 
the participants were already on pharmacotherapy for previously known or diagnosed depression, 
anxiety, or mood disorders.  However, the notification of providers of the scores on the PHQ-9 
and GAD-7 did not trigger a dose increase or counseling of the HF provider.  This is particularly 
enthralling because it indicates that providers in the acute care setting may not feel comfortable 
prescribing these types of medications. Alternatively, acute care providers may see mental health 
symptoms as a primary care issue for outpatient followed up.  This area needs further exploration 
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to determine the attitudes and beliefs of providers caring for the HF population on mental health 
in this patient population. 
Self-care, depression symptoms, and anxiety symptoms 
The SHSCF pilot program showed that there were changes in self-care, depression 
symptom, and anxiety scores measured between prior to discharge and at the 30-day follow-up.  
Specifically, in the intervention and control groups, depression symptom scores decreased, anxiety 
scores increased and self-care scores increased, all, though statistically non-significant, may be 
clinically significant.  
In terms of the observed increase in self-care scores, it is not surprising that the telehealth 
methods in this pilot study produced such a positive effect.  According to Ditewig, Blok, Havers 
& van Veenendaal (2010), patient education is used frequently in HF self-management programs, 
especially to help patients recognize signs and symptoms of decompensation early enough to seek 
help from a medical professional.  Furthermore, programs that included telemonitoring or HF 
management programs centered around education often result in improved self-care behaviors, 
increased self-efficacy, and helped participants to feel more accountable for their care (Baker et 
al., 2011; Ciere et al., 2012; Radhakrishnan & Jacelon, 2012; Seto et al., 2012).  Several researchers 
have stressed the importance of patient education on self-care (Stromberg, 2005; Gonseth, Guallar-
Castillon, Banegas, and Rodriguez-Artalelo, 2004; Gwadry-Sridhar, Flintoft, Lee, Lee, and 
Guyatt, 2004; McAllister, Lawson, Teo, and Armstrong, 2001) but note that education alone is not 
sufficient to improve self-management skills. Thus, the findings from this pilot study are congruent 
with current research on HF self-care and suggest a need for more evidence related to telehealth 
interventions. 
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Furthermore, in the intervention group, depression symptom scores decreased compared to 
those participants in the control group whose scores increased albeit non-significantly.    It is well 
understood that the co-morbid presence of depression in HF patients may impact patient treatment 
adherence and self-management.  Preventing the progression or worsening of HF is often centered 
on medical management including pharmacotherapies in this patient population; this has been 
reported to have a negative correlation with depression (Morgan et al., 2006).  Patients who have 
depression symptoms and HF are significantly less likely to adhere to their medication regimen 
(Morgan et al., 2006).  Additionally, other self-care activities such as dietary modification and 
physical functioning may be improved with interventions that target depression symptoms in this 
population (Riegel et al., 2009; Rutledge, Reis, Linke, Greenberg, & Mills, 2006; Dusseldorp, van 
Elderen, Meulman, & Kraaij, 1999).  Some researchers suggest that depression may inhibit optimal 
self-care activities and that poor self-care is related to depression symptoms (Cameron, Worrall-
Carter, Page, Riegel, Lo, & Stewart, 2010; Morgan et al., 2006; Riegel, Vaughan Dickson, 
Goldberg, & Deatrick, 2007). Hence, interventions targeting patients with HF who have depression 
and poor self-care may result in better outcomes than just focusing on either depression or self-
care alone (Riegel et al., 2009).  This evidence highlights the importance of this pilot study because 
it combines both the knowledge of self-care skills with screening for depression symptoms.  
It has been noted that research in HF patients who also have anxiety is limited.  In the 
scientific statement from the American Heart Association on the promotion of self-care in persons 
with HF, researchers suggest that the presence of anxiety is likely to negatively impact self-care 
(Riegel et al., 2009).  This may be due to symptoms such as generalized fatigue or exhaustion, 
impaired concentration, muscle tension, insomnia or sleeping difficulties, and irritability that 
prevent the engagement in self-care tasks (American Psychiatric Association, 2013, p. 222).  It is 
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worth mentioning that anxiety has been found to contribute to a higher poor functional status and 
more physical symptoms in patients with chronic medical conditions even after controlling for 
severity of disease (Katon, Lin, & Kroenke, 2007).  Recently, high levels of anxiety were reported 
to have a negative association with self-care management in HF patients; those patients also 
indicated a decreased likelihood to consult their providers for medical advice as well (Lee et al., 
2015).  Thus, there may be delayed provider communication as well as self-care skills that 
contribute to poorer clinical outcomes.  With limited knowledge about anxiety in HF populations, 
future studies should focus on the relationship between Anxiety symptoms and self-care behaviors.   
Quality of Life 
 This study found that there was no significant difference in quality of life between the 
intervention and control groups. It is well known that there is a negative association between 
depression, anxiety, and quality of life in patients with HF compared to healthy aging adults (Heo 
& Moser et al, 2007; Goodman, Firouzi, Banya, Lau-Walker, & Cowie, 2013;  Hallas, Wray, 
Andreou, & Banner, 2011; Serafini et al., 2013; Nesbitt et al., 2014; Cully, Phillips, Kunik, 
Stanley, & Deswal, 2010; Paukert, LeMaire, & Cully, 2009; Heo, Doering, Widener, & Moser, 
2008; Shen et al., 2011; Staniute et al., 2015; Chung et al., 2009). Reduced quality of life indicated 
by a high score on the MLWHFQ-21 suggests that those patients with depression or anxiety 
symptoms are consequently less likely to adapt to changes in behavior resulting in poorer self-care 
(Albert & Zeller, 2009; Hallas et al., 2011). Furthermore, the presence of psychological co-
morbidities may distort the expectation of the illness and amplify the severity of disease, leading 
to reduced self-care and inability to cope with the diagnosis of HF (Goodman et al., 2013). 
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Readmissions 
The findings regarding readmissions demonstrated that there was no difference in hospital 
readmissions for the intervention and control groups 30 days after discharge.  It is noted that none 
of the participants readmitted in the intervention group had a primary diagnosis of HF 
decompensation upon return to the hospital; these readmissions were attributed to bleeding 
complications from the participants LVAD and ventricular dysrhythmias requiring electrical 
defibrillation. Comparatively, two of the three patients readmitted within the control group were 
related to HF exacerbations. This finding is interesting because it may suggest that the intervention 
group may have positively benefitted from HF education because of improved self-care; there were 
less readmissions related to HF decompensation in the intervention group compared to the control 
group.  Previous studies have noted that HF related hospitalizations were reduced in patients who 
were part of a telemonitoring or telehealth intervention study (Austin et al., 2012; Baker et al., 
2011; Chaudhry et al., 2010; Dendale et al., 2012; Feltner et al., 2014; Inglis et al., 2011; Koehler 
et al., 2011; Kurtz et al., 2011; Schmidt et al., 2010; Seto et al., 2012; Weintraub et al., 2010). 
Given the limited sample size for this pilot study, a larger, better powered study is needed to further 
determine the effects of telehealth interventions on HF related readmissions. 
Patient Satisfaction 
 Overall, the SHSCF pilot study was well received by participants. The participants in the 
intervention group had positive reflections about the program and the information it provided about 
self-care skills and management.  Even if participants verbalized that they already knew the 
information, they noted an enhanced comfort in their confidence about the information as well as 
improved positivity and optimism. Text messages were evaluated for the preferred time of day but 
most participants did not see the need to change the timing. The biggest complaint about the 
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program was that participants found it difficult to complete the telephone survey at the 30-day 
follow-up and would have preferred a mailed hard copy of the forms instead.  However, there was 
a 90% follow-up rate so it is possible that a mailed copy of the forms could be used as an alternative 
method if telephone interview was not achievable. 
Feasibility of Study  
There are many areas of improvement for this pilot program. These areas include study 
design, participant recruitment and enrollment, and post intervention follow-up. 
Controlling for Differences in the Control vs. Intervention Group 
Due to significant differences in the control and intervention group for educational level 
and HF class, it may have been beneficial to stratify the sample by NYHA Class.  Perhaps, half 
of each group would have the same number of participants with NYHA class I-II and the other 
half have NYHA class III-IV in both the intervention and control groups.  This may have 
impacted the average score for the PHQ-9 and the GAD-7 since patients with advanced disease 
may be more likely to have depression and anxiety symptoms.  Additionally, controlling for 
educational level may have impacted SCHFI scores.  The mean SCHFI score of the sample was 
higher than expected (mean SCHFI= 61.5, SD=11.9) and may be related to a higher educational 
level in the intervention group. 
Timeline 
This pilot program projected a potential sample size of 50 participants.  A power analysis 
was not required given that this was a pilot feasibility study.  The sample size of fifty was chosen 
to match the average monthly discharge rate of HF patients at the University of Kentucky.  
However, only 20 patients were enrolled in the pilot study due to time constraints.  For a future 
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study, a power analysis should be performed by potentially using the preliminary findings of this 
study. Such a powered study could make the study’s conclusions more meaningful. 
Text Messaging Delivery 
The website used for delivery of the HF self-care text messages was not reliable.  There 
were 3 separate occasions in which the website had downtime and was not actively delivering 
text messages.  The first time this occurred was when the only participant in the intervention 
group was receiving text messages.  The website was unavailable for 48 hours and was 
successfully back up the following Monday.  This could have been because it occurred over the 
weekend.  There was another instance where the website was down for less than 24 hours 
affecting, 4 participants; those participants missed 1 message.  At this point during the pilot, 
there was decreased response time from the website host about ensuring delivery of the text 
messages. Finally, the last time the website was unavailable was for five days, affecting 5 
participants.  The participants still received all messages but there was a gap in the messages of 5 
days.  Those participants were followed up with post self-care, depression, and anxiety scores 
after they completed the intervention (although it was longer than 30 days).   It was decided to 
switch website hosts at this point to ensure adequate dosing of the intervention.  The new website 
host had great customer service and was costlier.  It would have been beneficial to choose a more 
expensive host in the beginning of the study to prevent technology failures. 
Inclusion Criteria: Ownership of a Cell Phone 
As mentioned earlier, many participants were excluded due to the inability to receive text 
messages on a cellular phone or the lack of a smart phone.  Perhaps the use of text messaging 
through Apple, Android, or Microsoft tablets could have allowed certain eligible patients to 
participate in the study if this option was available.  Also, funding available to purchase “go-
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phones” could have allowed the inclusion of more patients.  Grant funding would have improved 
the number of participants eligible to participate in the study. 
Single Institution 
The results found from this pilot study are applicable to academic medical centers who 
offer similar therapies for advanced HF including LVADs, extracorporeal membrane 
oxygenation (ECMO), milrinone therapy, inhaled Flolan, and transplantation.  The pilot 
feasibility study limits the generalization to a patient sample in a rural setting compared to the 
urban, academic center in which patients are referred from across the region. 
Recruitment 
This study did not recruit from other services outside of Cardiology.  This could have led 
to an under-inclusion of eligible participants located on internal medicine teams or in medical 
intensive care units in other areas of the hospital.  
Enrollment 
Although the study personnel included many people, the PI was the only person to enroll 
patients for the program.  This often times, was very time consuming especially if a patient did 
not have their glasses to read the outcomes tools or had trouble hearing.  The enrollment process 
took on average approximately 40 minutes to over an hour to complete.  This was due to 
interruptions in the delivery of informed consent as well as the time it took for the participant to 
fill out the tools.  Interruptions in enrollment are anticipated and included visits from home 
health agencies delivering equipment (oxygen tanks, walkers, canes, shower equipment), 
members of the patient care team (physicians, nurse practitioners, nurses, pharmacists, physical 
therapists, occupational therapists), and other companies such as Infusion partners (sets up home 
milrinone infusions) or LifeVest representatives.  It may have been easier to collect data from the 
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tools on an iPad and have everything stored in REDCap (Research Electronic Data Capture) for 
easy access; this is a secure, web-based application designed exclusively to support data capture 
for research studies.  This also would have avoided manual data entry that could result in 
unintended data entry error. 
Follow-up 
Thirty days after discharge, each patient was interviewed by telephone to collect post 
intervention data for self-care, depression symptoms, and anxiety symptoms.  They were also 
administered the MLWHFQ-21 to assess quality of life which contributed to a lengthy 
conversation.  For some, the phone calls lasted 12 minutes at minimum to a maximum time of 1 
hour or more.  It was noted in the patient satisfaction survey that it would have been easier to fill 
out the forms again in person if the surveys were sent to each participant by mail.  Also, the use 
of electronic research data capture software such as REDCap or Survey Monkey could have 
promoted follow up response for those participants who are younger and do not converse on the 
phone regularly. 
Limitations 
There were several limitations for this study which, when addressed, can contribute to the 
better design of future studies that use telehealth technology.  First, patients recruited for the 
study were unable to be a part of other research studies or join a study after enrollment in the 
SHSCF pilot program.  This limited the sample population for the study and often prevented 
participants from enrolling.  During the first 3 weeks of this pilot, recruitment for the study was 
low so the protocol was modified to include patients with LVADs. This was not optimal 
considering that patients with LVADs have special access and support from nurse coordinators 
compared to those patients whose HF is not advanced enough to require mechanical device 
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support therapy.  This may have contributed to a moderately high average SCHFI score of 61.5 
out of 100 possible points which was higher than expected.  This may indicate a falsely high self-
care score if those patients who have LVADs score higher on the SCHFI tool.  However, it is 
likely that the majority of the education given to LVAD patients by their coordinators is mostly 
device related. 
Other problems related to the recruitment and enrollment of patients include the lack of a 
cellular device or data service to receive the daily text messaging intervention.  This limited the 
population that met inclusion criteria and contributed to the small sample size of the pilot 
program.  Disadvantages, including absent study personnel to recruit participants as well as a 
single institution, also contributed to the small sample size and limit generalizability of findings. 
Second, it is possible that the average depression and anxiety scores (mean PHQ-9=7.2; 
mean GAD-7= 5.3) indicating mild symptoms were related to the Hawthorne effect.  The 
Hawthorne effect explains how a person’s behavior or responses can change when they know 
they are being observed.  With sensitive issues such as the question about thoughts of self-harm 
or harm to others on the PHQ-9, it is possible that participants may be reluctant to answer 
truthfully.  It is noteworthy that the design of this protocol included requirements set forth by the 
Institutional Review Board (IRB) to ensure patient safety.  This means that in the informed 
consent form, each participant was notified that if they scored moderate, moderately high, or 
severe on the PHQ-9 or the GAD-7 their provider would be notified.  The risks and possible 
outcomes of these scores were also described thoroughly to teach patient per protocol.  The 
possibilities outlined included the start of new medications, initiation of counseling, or 
consultation of Psychiatric services that would be the financial responsibility of the participant. 
This could have a been a barrier to the participant answering questions about depression and 
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anxiety symptoms openly and honestly due to certain determinants of health such as 
socioeconomic status or access to care. 
Other limitations included differences in education and NYHA class between the 
intervention and control group.  Controlling for these variables, particularly NYHA class may 
have produced different results on self-care in addition to impacting depression and anxiety 
symptom scores.  This can be attributed to the worsened functional status and increase symptoms 
experienced by persons with advanced HF; this is likely to affect psychological outcomes such as 
depression, anxiety, and quality of life. 
 The final limitation to the study was the missing data from two participants after the 30-
day period post discharge.  One participant, in the control group, unexpectedly died and the other 
participant, in the intervention group, was unable to be reached by telephone. It is unlikely that 
this would have contributed to statistical significance of the study findings, though, because of 
the overall small study sample size.  
Conclusion 
 Self-management programs such as the SHSCF pilot program offer hope to providers and 
patients as they transition from an acute care facility to home.  Specifically, telehealth methods 
show promise in increasing provider and patient communication as well as access to specialty 
care.  This program highlights how the routine screening for depression and anxiety symptoms 
could be beneficial in the HF population at the time of discharge.  Encompassing a holistic 
approach to care through the evaluation of emotional, and not just physical, health is important to 
overall health and wellness.  This pilot study laid the foundation for designing and implementing 
a larger study in the future.  Findings from this study help to emphasize that HF self-
management programs are multifaceted and incorporate many elements that promote self-care.  
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Table 1 
Smart Heart Randomization  
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Table 2 
Outcome Evaluation Design 
Outcome Evaluation 
Outcome Measures Design Sources of Data Data Analysis 
Self-care SCHFI scores before the 
intervention (at discharge) 
and after the intervention 
Pretest-
posttest 
SCHFI instrument 
collected from 
patient 
Paired t-test 
Difference in 
30 day 
hospital 
readmission 
rates 
Readmission rate for heart 
failure patients 30 days after 
discharge in control vs. 
experimental group (number 
of readmissions per 50 
patient with heart failure) 
Post-test 
only 
Electronic Medical 
Record and 
telephone 
interview on day 
31 
Chi-squared 
analysis 
Anxiety 
symptoms 
GAD-7 Pretest-
posttest 
GAD-7 score 
collected from 
patient 
Paired t-test 
Depressive 
symptoms 
PHQ-9 Pretest-
posttest 
PHQ-9 score 
collected from 
patient 
Paired t-test 
Difference in 
quality of life 
1 month after 
discharge. 
Minnesota Living with 
Heart Failure Questionnaire 
(MLHFQ) with scores are 
0-105 from best to worst; 
scores for experimental vs. 
control group 
Post-test 
only 
Telephone 
interview 
Minnesota Living 
with Heart Failure 
Questionnaire 
(MLHFQ) 
Chi-squared 
analysis 
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Table 3 
University of Kentucky HF Payer Source 
Payor Source FY 2014 
Mix (%) 
FY 2015 
Mix (%) 
Govt/Other 4.0% 4.1% 
Managed Care 10.0% 10.1% 
Medicaid 18.5% 20.9% 
Medicare 64.6% 64.0% 
Self-Pay/Charity 2.9% 0.9% 
 
(A. Carr, personal communication, August 3, 2015) 
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Table 4 
University of Kentucky Inpatient Discharges by Age 
Age Groups FY 2014 FY 2015 
Age 0-18 54 41 
Age 19-44 314 374 
Age 45-64 1,537 1,717 
Age 65+ 1,691 2,048 
Grand Total 3,596 4,180 
 
(A. Carr, personal communication, August 3, 2015) 
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Table 5 
Participant Demographics and Baseline Information 
 Intervention 
(n=8) 
 
n (%) 
Control 
(n=12) 
 
n (%) 
p 
Age, Mean (SD) 49.5 (13.2) 48.8 (16.6) .93 
BMI, Mean (SD) 34.9 (15.1) 34.4 (9.9) .93 
SCHFI, pre 67.6 (12.1) 57.4 (10.2) .06 
PHQ-9, pre 6.8 (3.8) 7.5 (6.0) .76 
GAD-7, pre 2.8 (3.0) 7.0 (6.4) .10 
Gender 
   Male 
   Female 
 
5 (62.5) 
3 (37.5) 
 
9 (75.0) 
3 (25.0) 
.55 
Ethnicity 
  Caucasian 
  African-American 
 
8 (100.0) 
0 (0.0) 
 
9 (75.0) 
3 (25.0) 
.19 
Marital status 
  Married 
  Non-married 
 
3 (37.5) 
5 (62.5) 
 
5 (41.7) 
7 (58.3) 
.61 
Education 
  Less than high 
  school 
  High school 
  Above high school 
 
 
0 (0) 
5 (62.5) 
3 (37.5) 
 
 
3 (25.0) 
9 (75.0) 
0 (0) 
.02 
Residence 
  Urban 
 
5 (62.5) 
 
7 (58.3) 
.85 
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  Rural 3 (37.5) 5 (41.7) 
Household income 
   <20,000 
   20,000+ 
 
4 (50.0) 
4 (50.0) 
 
10 (83.3) 
2 (16.7) 
.14 
NYHA class 
   Class I 
   Class 2 
   Class 3 
   Class 4 
 
1 (12.5) 
4 (50) 
2 (25) 
1 (12.5) 
 
0 (0) 
2 (16.7) 
5 (41.7) 
5 (41.7) 
.04 
LVEF, Mean (SD) 27.1(19) 25.8 (15.1) .86 
LVEF 
   Preserved 
   Non-preserved 
 
2 (25.0) 
6 (75.0) 
 
1(8.3) 
11 (91.7) 
.34 
VAD 
   Yes 
   No 
 
4 (50.0) 
4 (50.0) 
 
2 (16.7) 
10 (83.3) 
.14 
PHQ-9 
  Mild 
  Moderate to Severe 
 
6 (75.0) 
2 (25.0) 
 
8 (66.7) 
4 (33.3) 
.69 
GAD-7 
  Mild 
  Moderate to Severe 
 
8 (100.0) 
0 (0.0) 
 
9 (75.0) 
3 (25.0) 
.13 
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Table 6 
Changes in SCHFI scores, PHQ-9 scores, and GAD-7 scores Pre and Post Intervention 
Variable Total Intervention Control 
 Pre Post Pre Post Pre Post 
 Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD 
SCHFI 61.1 11.2 65.2 9.2 65.7 11.7 67.6 9.6 58.2 10.3 63.6 9.0 
PHQ-9 6.9 5.2 6.7 5.5 6.9 4.1 5.6 2.6 7.0 6.0 7.4 6.8 
GAD-7 5.0 5.7 6.4 5.9 2.4 3.1 4.0 3.4 6.6 6.5 7.9 6.8 
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Figure 1. Participant Test Message 
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Figure 2. Average Texts Received of Smart Heart Participants 
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Figure 3. Discharge Medications for Smart Heart Participants  
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*Note: Higher SCHFI scores= better self-care 
*1= pre-intervention and 2=post intervention 
 
Figure 4. SCHFI Scores Pre and Post Intervention 
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*Note: Higher PHQ-9 scores= more depression symptoms 
*1= pre-intervention and 2=post intervention 
 
Figure 5. PHQ-9 Scores Pre and Post Intervention 
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*Note: Higher GAD-7 scores= more anxiety symptoms 
*1= pre-intervention and 2=post intervention 
 
Figure 6. GAD-7 Scores Pre and Post Intervention 
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*Note: Lower scores indicate a better quality of life 
 
Figure 7. Differences in MLWHFQ-21 Scores Post Intervention 
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Appendix A 
Self-Care of Heart Failure Index Tool 
 
Think about how you have been feeling in the last month or since we last spoke as you 
complete these items.  
 
SECTION A: 
Listed below are common instructions given to persons with heart failure. How routinely do you do the following? 
 
 Never or 
rarely 
Sometimes Frequently Always or 
daily 
1. Weigh yourself? 1 2 3 4 
2. Check your ankles for swelling? 1 2 3 4 
3. Try to avoid getting sick (e.g., flu shot, avoid ill 
people)? 
1 2 3 4 
4. Do some physical activity? 1 2 3 4 
5. Keep doctor or nurse appointments? 1 2 3 4 
6. Eat a low salt diet? 1 2 3 4 
7. Exercise for 30 minutes? 1 2 3 4 
8. Forget to take one of your medicines? 1 2 3 4 
9. Ask for low salt items when eating out or visiting 
others? 
1 2 3 4 
10. Use a system (pill box, reminders) to help you 
remember your medicines? 
1 2 3 4 
 
SECTION B: 
Many patients have symptoms due to their heart failure. Trouble breathing and ankle swelling are common 
symptoms of heart failure.  
 
In the past month, have you had trouble breathing or ankle swelling? Circle one. 
0) No 
1) Yes 
 
If you had trouble breathing or ankle swelling in the past month…  
(circle one number) 
 Have not 
had these 
I did not 
recognize it 
Not Quickly Somewhat 
Quickly 
Quickly Very 
Quickly 
How quickly did you recognize it as a 
symptom of heart failure? 
N/A 0 1 2 3 4 
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Listed below are remedies that people with heart failure use. If you have trouble breathing or ankle swelling, 
how likely are you to try one of these remedies? 
 
(circle one number for each remedy) 
 Not Likely Somewhat 
Likely 
Likely Very Likely 
11. Reduce the salt in your diet 1 2 3 4 
12. Reduce your fluid intake 1 2 3 4 
13. Take an extra water pill 1 2 3 4 
14. Call your doctor or nurse for guidance 1 2 3 4 
 
15. Think of a remedy you tried the last time you had trouble breathing or ankle swelling,  
 
(circle one number) 
 I did not try 
anything 
Not Sure Somewhat 
Sure 
Sure Very Sure 
How sure were you that the remedy 
helped or did not help? 
0 1 2 3 4 
 
SECTION C:  
In general, how confident are you that you can:  
 Not Confident Somewhat 
Confident 
Very 
Confident 
Extremely 
Confident 
16. Keep yourself free of heart failure symptoms? 1 2 3 4 
17. Follow the treatment advice you have been 
given? 
1 2 3 4 
18. Evaluate the importance of your symptoms? 1 2 3 4 
19. Recognize changes in your health if they occur? 1 2 3 4 
20. Do something that will relieve your symptoms? 1 2 3 4 
21. Evaluate how well a remedy works? 1 2 3 4 
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Appendix B 
Text Messaging Comfort Survey 
 
 
1. Do you own a smart phone (circle one)    Yes  No 
 
2. Do you have an unlimited text messaging plan? (circle one)  Yes  No 
 
3. Are you able to receive text messages? (circle one)   Yes  No 
 
4. Do you know how to open and view a text message? (circle one) Yes   No 
 
5. Do you carry your phone frequently?  (circle one) 
 
Always Sometimes Never/Seldom 
 
6. Have you ever used text messaging before? (circle one)  Yes  No 
7.  
8. Please describe how many text messages you usually receive each day (circle one) 
 
1-5 messages per day  6-10 messages per day 
 
11-20 messages per day >20 messages per day 
11-21  
 
From “A Text Messaging Intervention to Improve Heart Failure Self-Management After 
Hospital Discharge in a Largely African-American Population: Before-After Study,” by S. 
Nundy, R. Razi, J. Dick, B. Smith, A. Mayo, A. O’Connor, and D. Meltzer, 2013, Journal of 
Medical Internet Research, 15, p. e53. Copyright [2013] by S. Nundy, R. Razi, J. Dick, B. Smith, 
A. Mayo, A. O’Connor, and D. Meltzer. Reprinted [or Adapted] with permission from copyright:  
This is an open-access article distributed under the terms of the Creative Commons 
Attribution License (http://creativecommons.org/licenses/by/2.0/), which permits 
unrestricted use, distribution, and reproduction in any medium, provided the original 
work, first published in the Journal of Medical Internet Research, is properly cited.  
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Appendix C 
Patient Health Questionnaire-9 (PHQ-9) 
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Appendix D 
Generalized Anxiety Disorder-7 Scale (GAD-7) 
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Appendix E 
Minnesota Living with Heart Failure Questionnaire-21 (MLWHFQ-21) 
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Appendix F 
Patient Satisfaction Survey 
 
1. Did you find the Self Care Heart Failure Index Tool (SCHFI) you completed before 
discharge easy to use?  Yes No 
a. If no, why? 
__________________________________________________________________
__________________________________________________________________
__________________________________________________________________ 
 
2. Did you receive a hard copy of the self-care education before discharge?  
Yes No 
 
3. Did you feel overwhelmed by the education you received before discharge?  
Yes  No 
a. If yes, please describe: 
__________________________________________________________________
__________________________________________________________________
__________________________________________________________________ 
 
4. Is there any time of day you would like to receive the daily self-care telephone 
messages? Yes No 
a. if yes, please circle a time you prefer below. 
8:00am-12:00 pm 12:00pm-4:00 pm 4:00pm-7:00 pm after 7 pm 
5. Do you find the telephone based self-care messages helpful? Yes No 
 
6. Was it easy to take the post Self Care Heart Failure Index Tool (SCHFI) over the 
phone with the nurse? Yes No 
a. If no, please explain 
why______________________________________________________________
__________________________________________________________________
__________________________________________________________________
__________________________________________________________________ 
 
7. Are you with the Self-Care First Heart Failure Program? Yes No 
 
8. What parts of the program did you like? 
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
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___________________________________________________________________________
___________________________________________________________________________ 
9. What parts of the program did you dislike? 
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________ 
 
10. What parts of the program would you change? 
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________ 
 
Thank you for participating in the Smart Heart Self-Care First Pilot Program! We 
appreciate your support! Please let us know if there is anything we can do to make your 
experience better. 
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Appendix G 
Depression and Anxiety Screening Protocol 
 
Part I: Anxiety (GAD-7 Scale) 
 5: mild anxiety 
 10: moderate anxiety 
 15: severe anxiety 
 ≥ 10: probably diagnosis of GAD; must be further evaluated by Psychiatrist 
for official diagnosis (Psych Consult) 
 Consider starting SSRI; 1st line treatment for anxiety 
 May refer to Behavioral Therapy if already outpatient and patient expresses interest 
 
 
*Note: Patients who score > or equal to 10 will be reassessed 30 days after discharge for anxiety 
symptoms. 
 
Part II: Depression (PHQ-9) 
 0-4: none 
 5-9: mild depressive symptoms 
 10-14: moderate depressive symptoms 
 15-19: moderately severe depressive symptoms 
 20-27: severe depressive symptoms 
 ≥ 10: high specificity and sensitivity for major depressive disorder; 
must be further evaluate by Psychiatrist for diagnosis (Psych Consult) 
 Consider starting SSRI, SNRI, Buspirone, or other anti-depressants 
based on patient needs determined by provider 
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*Note: Patients who score > or equal to 10 will be reassessed 30 days after discharge for 
depression symptoms. 
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Appendix H 
Smart Heart Participant Recruitment Flyer 
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Appendix I 
Demographic Information Sheet 
 
Smart Heart 4 digit ID #: ___________________________________________________ 
Age: _____________________________________________________________________ 
County of Residence:  ______________________________________________________                                                                                                            
Family Contact and Phone Number ___________________________________________                                                                                  
 
Gender (circle one)   Male   Female 
Marital Status (circle one)   
Single   Married  Widowed   Divorced  
Number of Persons in Household: _____________________________________________ 
Race (circle one): 
Caucasian/White  African American  Latino/Hispanic  Asian American 
Pacific Islander 
Highest Education level completed (circle one): 
Less than high school  High school education/GED   College degree 
Graduate level degree 
Median Household Income (circle one): 
< $20,000/yr   $21,000-40,000/yr   $41,000-60,000  $61,000-80,000/yr 
$81,000-100,000/yr  > $100,000/yr 
NYHA Class: 
______(I) No limitation of physical activity. Ordinary physical activity does not cause undue 
fatigue, palpitation, dyspnea (shortness of breath) 
______(II) Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity 
results in fatigue, palpitation, dyspnea (shortness of breath) 
______(III) Marked limitation of physical activity. Comfortable at rest. Less than ordinary 
activity causes fatigue, palpitation, or dyspnea 
______(IV) Unable to carry on any physical activity without discomfort. Symptoms of heart 
failure at rest. If any physical activity is undertaken, discomfort increases 
SMART HEART PILOT PROGRAM   66 
 
 
 
To be completed by PI through review of medical records and interview: 
 
Left ventricular Ejection Fraction (EF):___________ Date: _________________ 
 
Review of Current Medications: 
 
 
 
 
 
Number of Readmissions in the last year at UK and other hospitals: _______   
Height: __________ 
Weight:__________ 
BMI: ____________ 
LVAD? (yes or no): ____________ 
Objective NYHA Class (A, B, C, or D): __________ 
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Appendix J 
Text Messaging Plan 
 
DIET/ 
FLUIDS 
MEDS WEIGHT SIGNS 
OF 
FLARE 
UP 
MEDS WEIGHT EXERCISE/ 
COPING 
Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 
Welcome to the Self- 
Care First Heart 
Failure Program! We 
are glad you have 
agreed to join our 
study. Heart failure 
means that your heart 
can’t pump as good 
as it used to. This 
causes low blood 
flow to other parts of 
the body and a weak 
heart. Self-care is the 
best way to manage 
your disease. Our 
goal is to increase 
your confidence so 
you can lead a 
healthy life! 
Take your medications 
as directed by your 
provider. Take each 
medicine at the same 
time of day and let 
your provider know of 
any side effects. If you 
miss a dose, take it as 
soon as you remember 
unless it is time for 
your next dose. Do not 
change the dose of the 
medicine or stop 
taking the medicine 
unless your provider 
tells you to. 
Weighing yourself daily 
can help alert you to 
extra fluid in the body. 
Weigh yourself the 
same time each 
morning, with the same 
amount of clothes, 
before you eat, and after 
urinating to get an 
accurate measure. 
Keep track of your 
weight on a calendar 
and call your provider if 
you gain more than 2 
pounds in 1 day. 
If you notice 
swelling of the 
ankles or lower 
legs, you may have 
too much fluid in 
the body. Tightly 
fitting shoes or 
clothes may also be 
a sign of a flare-up 
or worsening heart 
failure. Let your 
provider know if 
you have these 
signs. 
Drugs that end in –
olol are called beta 
blockers. Examples 
are carvedilol or 
metoprolol. They 
can lower blood 
pressure and slow 
down heart rate. 
These drugs can 
make you feel tired 
at first but over 
time help the heart 
pump better and 
prevent further 
damage! 
Make sure you are 
getting your daily 
weight in! Reach out 
to your provider if 
you are unable to get 
a scale for some 
reason. Sudden 
weight gain of more 
than 2 pounds in 1 
day or more than 5 
pounds in a week 
means you should 
call your provider! 
Some people may 
have follow-up visits 
after being 
hospitalized as soon 
as 7 days after 
discharge. Bring 
your calendar with 
your daily weights to 
your appointment 
and write down any 
questions you may 
have for your 
provider. Your 
provider may have 
you bring your 
medications as well. 
Day 8 Day 9 Day 10 Day 11 Day 12 Day 13 Day 14 
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Too much salt in the 
diet can cause your 
body to keep excess 
fluid. The daily goal 
of salt in the diet is 
less than 3 grams. 
Some foods high in 
salt are canned, 
dried, packaged, 
frozen, or fast foods. 
Try using salt 
substitutes to reduce 
your intake! 
Drug that end in –pril 
lower blood pressure 
and decrease the work 
of the heart. They are 
important for 
increasing strength of 
the heart. If you notice 
that you develop a 
cough with this 
medicine, contact your 
provider. 
Gaining weight 
suddenly or a steady rise 
in weight is the first 
warning sign of 
worsening heart failure. 
Remember to weigh 
yourself every day and 
keep track of your 
weight on a calendar or 
in a journal. If you gain 
more than 2 pounds in 1 
day or more than 5 
pounds in 1 week, call 
your provider. 
Your heart failure 
may be getting 
worse if you have 
trouble breathing 
with activity or at 
rest, if you wake up 
in the middle of the 
night short of 
breath, coughing, or 
need to use more 
pillows than normal 
to sit/sleep. Call 
your provider if you 
have these 
symptoms. 
Water pills help the 
body to get rid of 
excess fluid. These 
are drugs like 
furosemide, 
metolazone, or 
spironolactone. 
They can decrease 
swelling and make 
it easier for the 
heart to pump. 
Sometimes water 
pills cause low 
potassium levels. 
Your provider may 
have prescribed you 
potassium to take 
with your water 
pill. 
Daily weights can 
help keep you out of 
the hospital. 
Remember you are 
looking for a 2-pound 
weight gain in one 
day or a 5 pound 
weight gain in 1 
week. If you notice 
this trend, contact 
your provider 
immediately. 
They may have you 
take an extra water 
pill. 
Exercise in the form 
of simple activities 
such as walking is 
encouraged most 
days of the week. 
Rest as you need it 
and stop activity if 
you have chest pain, 
have trouble 
breathing, feel dizzy 
or lightheaded. 
Day 15 Day 16 Day 17 Day 18 Day 19 Day 20 Day 21 
Drinking too much 
fluid can lead to a 
flare-up. Keep track 
of what you are 
drinking and limit 
alcohol. Men should 
have less than 2 
drinks/day and 
women less than 1 
drink/day of alcohol. 
Try frozen fruits to 
quench your thirst or 
popsicles! 
Digoxin helps the 
heart pump stronger. It 
increases the amount 
of blood that your 
heart can pump with 
each beat. It lowers 
your heart rate and 
sometimes requires 
blood monitoring. 
Signs of toxicity 
include drowsiness, 
headache, confusion, 
vision 
changes, and GI 
symptoms. 
When you see your 
doctor at regular clinic 
appointments, don’t 
forget to bring your 
recorded weights! Your 
doctor may need to 
adjust your water pill 
dose based on this 
information. If you 
gain more than 2 
pounds in 1 day or 
more than 5 
pounds in 1 week, tell 
your provider. 
Warning signs of a 
flare- up include 
feeling weak, dizzy, 
or more tired than 
usual. You may 
have chest pain or a 
cough that won’t go 
away with 
increasing 
shortness of breath. 
You may have 
trouble 
remembering things 
or don’t feel 
hungry. Be sure to 
let 
you provider know 
if you are feeling 
this way. 
Hydralazine and 
drugs with “nitro” 
in them work 
together to treat 
heart failure. They 
lower blood 
pressure and make 
it easier for the 
heart to pump. Rise 
from a sitting to 
standing position 
slowly because 
these medications 
may decrease your 
blood 
pressure fast. 
Use the same scale 
every day at the same 
time with the same 
amount of clothes on. 
Put the scale on a flat 
surface. If you miss a 
day of weighing 
yourself, just weigh 
yourself the next 
morning! Don’t 
forget to call your 
provider if you gain 
more than 2 pounds 
in 1 day or more than 
5 pounds in 1 week. 
Depression can be 
common among 
people with heart 
failure. If you feel 
helpless, worthless, 
or that life is not 
worth living, be sure 
to share these 
feelings with your 
provider so they can 
help you. Seeking 
treatment for these 
feelings can help 
improve your 
overall health. 
Day 22 Day 23 Day 24 Day 25 Day 26 Day 27 Day 28 
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Low salt foods that 
are healthy include 
yogurt, fruit, fresh or 
frozen vegetables, 
whole oats, olive oil, 
vinegar, fresh meats, 
dried beans, unsalted 
margarine, graham 
crackers, lemon 
slices, frozen fruit, 
eggs, and fresh fish. 
Using a pill box or a 
reminder system can 
be useful when 
managing your 
medications. You can 
fill the pillbox at the 
start of each week so 
you don’t forget which 
medications to take 
every day. 
Hopefully you have an 
entire month filled in 
on your calendar with 
daily weights! Record 
your weight for each 
day on a calendar is the 
easiest way to keep 
track of weight gain. If 
you gain more than 2 
pounds in 1 day or 
more than 5 pounds in 
1 week, call your 
provider. 
For emergencies 
such as severe 
shortness of breath 
where you can’t 
catch your breath, 
severe chest pain 
that is not relieved 
by nitroglycerin or 
rest, pink, foamy 
mucus with cough, 
continuous rapid or 
irregular heartbeat, 
passing out, 
fainting, or stroke 
like symptoms such 
as numbness of 
weakness on one 
side of your body 
(face, arm, and 
legs) call 911. 
Have a family 
member or friend 
help you with your 
medications. It is 
the best way to 
include them in 
your care and it 
gives you 
something to do 
together! They can 
help you with your 
pill calendar or take 
you to the 
pharmacy to refill 
prescriptions. 
Recording your 
weight before 
breakfast and after 
emptying your 
bladder with the 
same kind of clothes 
on can help you 
know when you 
might have a flare 
up. 
Remember you are 
looking for a 2 pound 
weight gain in 1 day 
or 5 pounds over 1 
week. 
Call your provider if 
you see this pattern! 
Get up and get 
dressed every day 
with a plan to do an 
activity you enjoy! 
For exercise safety 1) 
rest when you feel 
short of breath 2) 
wear good socks and 
shoes 3) start slow 
and 4) don’t push 
yourself on days you 
don’t feel well. 
Day 29 Day 30  
Fresh fruits and 
vegetables help keep 
your heart healthy. 
Pair them with fish, 
chicken, and other 
meats. Be sure not to 
add salt to your 
food! You can use 
substitutes such as 
pepper and 
seasonings from 
your local grocery 
store! 
Remember to talk to 
your doctor about 
medication side 
effects and cost. If 
you are having 
trouble getting your 
medicine or have 
questions, be sure to 
contact your 
provider! 
 
Bornstein et al. (2011) 
 
